Cancer Market Research Reports & Industry Analysis

Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.

Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.

The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.

Found 1840 publications
Cancer Diagnostics Markets in China US$ 4,000.00

China's demand for Cancer Diagnostics has grown at a fast pace in the past decade. In the next ... market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for ...

Apr, 2016 213 pages
Cancer Diagnostics Industry Forecasts - China Focus US$ 1,000.00

This study focuses on China’s Cancer Diagnostics industry forecasts. In the two past decades, the industry has been growing at a ... ) and long-term forecasts through 2020 and 2025 are presented. The primary and secondary research is done in China in order to access up-to-date ...

Apr, 2016 58 pages
Cancer Diagnostics Companies in China US$ 1,800.00

This study focuses on China’s Cancer Diagnostics industry assessments and company profiles. In the two past decades, the industry has been ... of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for ...

Apr, 2016 53 pages
OpportunityAnalyzer: Vasculitis - Opportunity Analysis and Forecast to 2024 US$ 9,495.00

OpportunityAnalyzer: Vasculitis - Opportunity Analysis and Forecast to 2024 Summary Vasculitis is a family of rare autoimmune diseases, causing inflammation of the blood vessels, ... vasculitis market? What do vasculitis specialists and key opinion leaders across the 7MM think about the evolving treatment landscape? What opportunities remain ...

Jan, 2016 258 pages
OpportunityAnalyzer: Small Cell Lung Cancer (SCLC) - Opportunity Analysis and Forecasts to 2024 US$ 9,495.00

OpportunityAnalyzer: Small Cell Lung Cancer (SCLC) - Opportunity Analysis and Forecasts to 2024 Summary Initially considered a curable disease due to substantial sensitivity to first-line chemotherapies, small cell lung cancer (SCLC ... of patients surviving one year or less after diagnosis. Unlike non-small cell lung cancer (NSCLC), in which major advances in treatment have been made following ...

Jan, 2016 230 pages
OpportunityAnalyzer: Hepatocellular Carcinoma - Opportunity Analysis and Forecasts to 2024 US$ 9,495.00

OpportunityAnalyzer: Hepatocellular Carcinoma - Opportunity Analysis and Forecasts to 2024 Summary Liver cancer is the second ... in men and the sixth leading cause of cancer death in women. Hepatocellular carcinoma (HCC) is the most dominant form of liver cancer, accounting for ...

Dec, 2015 237 pages
EpiCast Report: Bipolar Disorder - Epidemiology Forecast to 2024 US$ 3,995.00

EpiCast Report: Bipolar Disorder - Epidemiology Forecast to 2024 Summary Bipolar disorder, also known as bipolar depression or manic depression, is a psychological disorder that presents with severe shifts in mood from one ... among them. Scope The Bipolar EpiCast Report provides an overview of the risk factors, comorbidities, and global trends for bipolar spectrum disorder in the eight major ...

Mar, 2016 64 pages
Breast Cancer: Update Bulletin [March 2016] US$ 995.00

... with nab-paclitaxel for patients with metastatic triple- negative breast cancer (mTNBC); the US Food and Drug Administration (FDA) awarding ... of this expanded indication have on prescriptions of Ibrance and on those of Afinitor? Update Bulletins include expert insight and analysis based on FirstWord analyst re- ...

Mar, 2016
2016-2020 Cancer Diagnostics: A Market on the Verge of Explosion-Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence US$ 24,500.00

... report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends ... applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading players and potential market entrants; and ...

Mar, 2016 1200 pages
Global Lung Cancer Surgery Market (Devices & Treatment Outlook) Industry 2016 Market Research Report US$ 2,850.00

Global Lung Cancer Surgery Market (Devices & Treatment Outlook) Industry 2016 Market Research Report was a professional and depth research report on Global Lung Cancer Surgery Market (Devices & Treatment Outlook) industry that you would know the world's major regional market conditions of Lung Cancer Surgery Market (Devices & Treatment ...

Feb, 2015 156 pages
Frontier Pharma: Breast Cancer - First-in-Class Innovation Clustered Around Growth Factor Signalling Processes US$ 6,995.00

Frontier Pharma: Breast Cancer - First-in-Class Innovation Clustered Around Growth Factor Signalling Processes SUMMARY The breast cancer pipeline is the largest in the pharmaceutical industry, with ... deals landscape surrounding first-in-class products in breast cancer, and pinpoints opportunities for in-licensing. A brief introduction to breast cancer, including symptoms, pathophysiology, and an overview ...

Feb, 2016 79 pages
Epiomic Epidemiology Series: Stomach Cancer Forecast in 17 Major Markets 2016-2026 US$ 6,382.00

... Stomach Cancer include: History of stomach polyps or stomach lymphoma Family history of stomach cancer Family history of hereditary non-polyposis Colorectal cancer ... sourced from the proprietary Epiomic patient segmentation database. To ... patient registries, clinical trials and epidemiology studies. All of the ...

Mar, 2016 66 pages
United States Cancer Biomarker Market Opportunities, 2011 - 2021 US$ 2,500.00

... their market position in a highly competitive cancer biomarker market in the United States. “United States Cancer Biomarker Market Opportunities, 2011 - 2021” report elaborates the following aspects of cancer biomarker market in the United States: United States Cancer Biomarker Market Size, Share ...

Mar, 2015 117 pages
United States Breast Pumps Market Opportunities, 2011 - 2021 US$ 2,500.00

... competitive breast pumps market in the United States. “United States Breast Pumps Market Opportunities, 2011 - 2021” report elaborates the following aspects of breast pumps market in the United States: United States Breast Pumps Market Size, Share & Forecast Segmental Analysis – By Type (Manual Breast Pumps ...

Mar, 2015 90 pages
Generic Oncology Drug Market - Industry Trends, Manufacturing Process, Plant Setup, Machinery, Raw Materials, Cost and Revenue US$ 1,200.00

IMARC’s latest study “Generic Oncology Drug Market - Industry Trends, Manufacturing Process, Plant Setup, Machinery, Raw Materials, ... of the generic oncology market and who are the key players? What are the key success factors for generic oncology drug manufacturers? How are generic oncology drugs manufactured ...

Feb, 2016 40 pages
Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence US$ 4,995.00

Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence Summary Breast cancer, a malignant neoplasm, is the second-most ... ? Over the 2014-2021 period, the value of the Asia-Pacific markets for breast cancer therapeutics is expected to increase at a compound annual growth rate of 8.5%, from $1.9 billion ...

Feb, 2016 171 pages
Epiomic Epidemiology Series: Pancreatic Cancer Forecast in 17 Major Markets 2016-2026 US$ 6,382.00

... Pancreatic Cancer include: • Obesity • Diabetes • Jaundice • Pancreatitis • Gallbladder enlargement This report is built using data and information sourced from the proprietary Epiomic ... to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the ...

Feb, 2016 54 pages
Prostate Cancer: Update Bulletin [Feb 2016] US$ 995.00

... mCRPC, how likely is it that the agent will be utilised in a wider prostate cancer patient population? How do KOLs view the recommendations published by ... be used to treat patients with mCRPC in the pre-chemotherapy setting? Update Bulletins include expert insight and analysis based on FirstWord analyst re- ...

Feb, 2016
Pancreatic Cancer - Market Insights, Epidemiology and Market Size Forecast-2020 US$ 4,950.00

... DelveInsight’s “Pancreatic Cancer - Market Insights, Epidemiology and Market Size Forecast-2020” Reports provides an overview of the disease and global market size of the Pancreatic Cancer ... Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales ...

Feb, 2016 70 pages
Global Dendritic Cell Cancer Vaccine Market Outlook 2020 US$ 1,800.00

... Dendritic Cells New Vaccine Strategies That Exploit Dendritic Cells Biochemistry Dendritic Cell Cancer Vaccine Market & Clinical Insight Comparative Insight of Dendritic Cell Vaccines & Other Class of Vaccines Dendritic Cell Cancer Vaccine Pipeline by Country, Company, Indication & Phase Dendritic Cell Cancer ...

Mar, 2016 213 pages
2016 Switzerland Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Sweden Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Slovenia Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Slovakia Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Romania Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Portugal Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Poland Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Norway Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Netherlands Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Malta Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Lithuania Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Latvia Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Ireland Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Iceland Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Hungary Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Greece Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Finland Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Estonia Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Denmark Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Czech Republic Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales... US$ 4,850.00

... numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines ...

Feb, 2016 535 pages
2016 Cyprus Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Canada Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Bulgaria Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Belgium Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Austria Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
2016 Australia Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report-over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Feb, 2016 535 pages
A 28-Country Survey of the European Tumor Marker Diagnostics Market: Sales Forecasts, Supplier Shares-Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical... US$ 43,500.00

This new 28-country survey from VPGMarketResearch.com contains over 925 pages and 366 tables. The survey is designed to assist diagnostics industry executives ... and market shares of major cancer diagnostic product suppliers in major countries by individual test Five-year test volume and sales forecasts ...

Feb, 2016 925 pages
A 33-Country Survey of the Tumor Marker Diagnostics Market: Sales Forecasts, Supplier Shares-Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical... US$ 58,600.00

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives ... and market shares of major cancer diagnostic product suppliers in major countries by individual test. Five-year test volume and sales forecasts ...

Feb, 2016 1300 pages
Solid Tumor Testing Market in the US 2016-2020 US$ 2,500.00

... ABOUT SOLID TUMOR TESTING MARKET IN THE US Solid tumor testing or screening is done for the early detection of cancer, enabling effective ... of the solid tumor testing market in the US for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of solid tumor testing products ...

Feb, 2016 50 pages
Peripheral Lung Cancer -Pipeline Insights, 2016 US$ 1,450.00

... development partner and chemical information Comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, Preclinical and Discovery stages Coverage of the Peripheral Lung Cancer pipeline ...

Feb, 2016 80 pages
1 2 3 4 5 >
Skip to top